Dr. Sako Mirzaie holds dual PhDs in Biochemistry and Pharmaceutical Sciences. He specializes in the design of targeted drug delivery systems, leveraging a multidisciplinary approach that includes molecular dynamics simulations, molecular docking, quantum mechanics calculations, artificial intelligence, and wet lab experiments. His research focuses on developing innovative treatments for diabetes, cancer, and Alzheimer's disease by precisely targeting key biological pathways.